Chemotherapy of murine ovarian carcinoma by methotrexate-antibody conjugates
- 1 July 1977
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 20 (7) , 950-952
- https://doi.org/10.1021/jm00217a018
Abstract
Antibodies with specificity for an experimental ovarian carcinoma were coupled to methotrexate by 2 procedures. Water soluble carbodiimide gave effective coupling, but a large proportion of the conjugate was rendered insoluble, presumably due to alteration or aggregation of the antibodies. A modification of the mixed anhydride procedure gave rise to products which were completely soluble and allowed a high degree of coupling to be achieved. In vivo testing of the conjugates revealed a significant increase in survival time in treated mice when compared to a variety of control groups. These included groups receiving antiserum or drug alone, mixtures of the 2 and conjugates of normal .gamma.-globulin with methotrexate. The results provide added support for the concept that tumor associated antibodies coupled to cytotoxic agents are more effective than single agents or noncoupled mixtures of agents.This publication has 0 references indexed in Scilit: